A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival

Blood

Volumn 101, Issue 6, 2003, Pages 2363-2367

  Hans, Christine P ^a   Weisenburger, Dennis D ^a,b   Vose, Julie M ^a   Hock, Lynette M ^a   Lynch, James C ^a   Aoun, Patricia ^a   Greiner, Timothy C ^a   Chan, Wing C ^a   Bociek, Robert G ^a   Bierman, Philip J ^a   Armitage, James O ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; BLEOMYCIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; MITOXANTRONE; PREDNISONE; PROCARBAZINE; VINCRISTINE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER GRADING; CANCER SURVIVAL; CYTOLOGY; DISEASE COURSE; FEMALE; FOLLICULAR LYMPHOMA; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0037443485     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-07-2298     Document Type: Article

References (28)

1. The Non-Hodgkin's Lymphoma Classification Project: a clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood. 1997;89:3909-3918.
2. Osborne CK, Norton L, Young RC, et al. Nodular histiocytic lymphoma: an aggressive nodular lymphoma with potential for prolonged disease-free survival. Blood. 1980;56:98-103.
3. Glick JH, McFadden E, Costello W, Ezdinli E, Berard CW, Bennett JM. Nodular histiocytic lymphoma: factors influencing prognosis and implications for aggressive chemotherapy. Cancer. 1982;49:840-845.
4. Kantarjian HM, McLaughlin P, Fuller LM, Dixon DO, Osborne BM, Cabanillas FF. Follicular large cell lymphoma: analysis and prognostic factors in 62 patients. J Clin Oncol. 1984;2:811-819.
5. Stewart ML, Felman IE, Nichols PW, Pagnini-Hill A, Lukes RJ, Levine AM. Large noncleaved follicular center cell lymphoma. Clinical features in 53 patients. Cancer. 1986;57:288-297.
6. Anderson JR, Vose JM, Bierman PJ, et al. Clinical features and prognosis of follicular large-cell lymphoma: a report from the Nebraska Lymphoma Study Group. J Clin Oncol. 1993;11:218-224.
7. Bartlett NL, Rizeq M, Dorfman RF, Halpern J, Horning SJ. Follicular large-cell lymphoma: intermediate or low grade? J Clin Oncol. 1994;12:1349-1357.
8. Martin AR, Weisenburger DD, Chan WC, et al. Prognostic value of cellular proliferation and histologic grade in follicular lymphoma. Blood. 1995;85:3671-3678.
9. Wendum D, Sebban C, Gaulard P, et al. Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol. 1997;15:1654-1663.
10. Rodriguez J, McLaughlin P, Hagemeister FB, et al. Follicular large cell lymphoma: an aggressive lymphoma that often presents with favorable prognostic features. Blood. 1999;93:2202-2207.
11. Rodriguez J, McLaughlin P, Fayad L, et al. Follicular large cell lymphoma: long-term follow-up of 62 patients treated between 1973-1981. Ann Oncol. 2000;11:1551-1556.
12. Miller TP, LeBlanc M, Grogan TM, Fisher RI. Follicular lymphomas: do histologic subtypes predict outcome? Hematol Oncol Clin North Am. 1997;11:893-900.
13. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361-1392.
14. Nathwani BN, Harris NL, Weisenburger DD, et al. Follicular lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyons, France: IARC Press; 2001;162-167.
15. Mann RB, Berard CW. Criteria for the cytologic subclassification of follicular lymphomas: a proposed alternative method. Hematol Oncol. 1983;1:187-192.
16. Ott G, Katzenberger T, Lohr A, et al. Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. Blood. 2002;99:3806-3812.
17. Warnke RA, Kim H, Fuks Z, Dorfman RF. The coexistence of nodular and diffuse patterns in nodular non-Hodgkin's lymphomas: significance and clinicopathologic correlation. Cancer. 1977;40:1229-1233.
18. Horning SJ, Weiss LM, Nevitt JB, Warnke RA. Clinical and pathologic features of follicular large cell (nodular histiocytic) lymphoma. Cancer. 1987;59:1470-1474.
19. The International Non-Hodgkin's Lymphoma Prognostic Factors Project: a predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med. 1993;329:987-994.
20. Vose JM, Anderson JR, Bierman PJ, et al. Comparison of front-line chemotherapy for aggressive non-Hodgkin's lymphoma using the CAP-BOP regimens. Semin Hematol. 1994;31(2 suppl 3):4-8.
21. Vose JM, Weisenburger DD, Lynch JC, et al. CNOP for diffuse aggressive non-Hodgkin's lymphoma: the Nebraska lymphoma study group experience. Leuk Lymphoma. 2002;43:799-804.
22. The Non-Hodgkin's Lymphoma Pathologic Classification Project: National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. Cancer. 1982;49:2112-2135.
23. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
24. Peto R, Pike MC, Armitage P, Breslow NE. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II: analysis and examples. Br J Cancer. 1977;35:1-39.
25. Cox D. Regression models and life-tables. J R Stat Soc. 1972;34:187-220.
26. Cox DR. Partial likelihood. Biometrika. 1975;62:269-276.
27. LeBlanc M, Crowley J. Survival trees by goodness of split. J Am Stat Assoc. 1993;88:457-467.
28. Nathwani BN, Metter GE, Miller TP, et al. What should be the morphologic criteria for the subdivision of follicular lymphomas? Blood. 1986;68:837-845.